SCHEMBL22127960

SCHEMBL22127960

CC(C)(C)NC(=O)C(CCCCNC(=O)O)NC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 3/20 0.40
▸ SIRT6 Q8N6T7 1/20 0.40
▸ FOLH1 Q04609 1/20 0.38
▸ HDAC4 P56524 2/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ SIRT5 Q9NXA8 2/20 0.36
▸ CPB2 Q96IY4 1/20 0.36
▸ CTSS P25774 1/20 0.35
▸ CTSK P43235 1/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ EPHX1 P07099 1/20 0.34
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19115851 0.82 SIRT1 (0.42) SIRT1SIRT6FOLH1SIRT5SIRT2
SCHEMBL22026768 0.81 SIRT1 (0.41) SIRT1SIRT6FOLH1SIRT5EPHX1
SCHEMBL20952017 0.81 SIRT6 (0.35) SIRT1SIRT6FOLH1SIRT5CPB2
SCHEMBL23461405 0.81 SIRT6 (0.35) SIRT1SIRT6FOLH1SIRT5CPB2
SCHEMBL20950984 0.80 MMP1 (0.35) SIRT1SIRT6FOLH1CTSSCTSK
SCHEMBL22127910 0.79 DPP7 (0.50) PTGS1KCNH2MEN1GAAKMT2A
SCHEMBL16342128 0.78 FOLH1 (0.46) SIRT1SIRT6FOLH1SIRT5
SCHEMBL23039373 0.78 PRCP (0.47) HDAC4HDAC1CPB2MEN1KMT2A
SCHEMBL23039375 0.78 PRCP (0.47) HDAC4HDAC1CPB2MEN1KMT2A
SCHEMBL23039376 0.78 PRCP (0.47) HDAC4HDAC1CPB2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988561-B1 PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER XWPHARMA LTD (KY) 2023-06-07 — — EP disclosed
EP-3988561-A1 PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER XWPharma Ltd. (KY) 2022-04-27 — — EP disclosed
US-11312703-B2 Reactive oxygen species scavengers and use for treating diseases XWPharma Ltd. (KY) 2022-04-26 — — US disclosed
EP-3679051-B1 PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER XWPHARMA LTD (KY) 2021-12-29 — — EP disclosed
US-20210061791-A1 REACTIVE OXYGEN SPECIES SCAVENGERS AND USE FOR TREATING DISEASES XWPharma Ltd. (KY) 2021-03-04 — — US disclosed
US-10889572-B2 Reactive oxygen species scavengers and use for treating diseases XW LABORATORIES INC. (KY) 2021-01-12 — — US disclosed
US-20200199108-A1 PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER XWPharma Ltd. (KY) 2020-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10889572-B2 Reactive oxygen species scavengers and use for treating diseases GSR, TXNRD2, GPX1 SIRT1 1370/4885SIRT6 1746/4885FOLH1 2190/4885
US-20210061791-A1 REACTIVE OXYGEN SPECIES SCAVENGERS AND USE FOR TREATING DISEASES GSR, TXNRD2, GPX1 SIRT1 1370/4885SIRT6 1746/4885FOLH1 2190/4885
US-20200199108-A1 PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER GPX1, SOD1, GPX4 SIRT1 2073/4885SIRT6 2989/4885FOLH1 1970/4885
US-11312703-B2 Reactive oxygen species scavengers and use for treating diseases GSR, TXNRD2, GPX1 SIRT1 1370/4885SIRT6 1746/4885FOLH1 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback